Hart Biologicals has announced the availability of its new Ristocetin MEA Test kit.
Hart Biologicals recently showcased an innovative product at the UK NEQAS for Blood Coagulation Clinical and Laboratory Haemostasis meeting at Sheffield Hallam University.
Hart Biologicals is getting ready to present at this year’s UK NEQAS at Sheffield Hallam Universityand will be bringing along one of its latest products, the T-TAS 01.
A member of the Hart Biologicals team is backing a charity which supports Police Officers across the UK after a close family friend sadly passed away.
Mental health first aiders have been trained to raise awareness and promote positive Mental Health and Wellbeing in their workplace.
A rebooted Hart Biologicals website has improved the online experience for its users.
As part of its continuing product development programme, Hart Biologicals is pleased to announce the availability of a new range of platelet aggregation reagents specifically designed for use with whole blood samples using Multiple Electrode Aggregometry (MEA) systems.
For the past four years Hart Biologicals, specialists in haemostasis and in vitro diagnostics, has been working alongside one woman with a unique set of requirements.
As part of its continuing product improvement programme Hart Biologicals is making further changes to its (HB-4452-FG) PT/INR Line Set.
Hart Biologicals is made of many departments that work together to ensure the smooth working of the company.
Alexander Ebinger, Head of Research and Development and Christian Genz, Research and Development Supervisor, introduce us to R&D and take us through how the department fits into the structure of the medical manufacturing company.
Hart Biologicals, the haematology and thrombosis specialist, has been successful in placing its Thrombistat MC1WB systems in a strategic location in the South East of England.
Quality Assurance Officer, Kelly Ward has been with Hart Biologicals for over two years and in that time has become an integral part of the QA Department.